(Q51820667)

English

Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

membrane protein

1 reference

based on heuristic

inferred from title

author name string

Ravendra Garg

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

J K Srivastava

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

A Pal

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

S Naik

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

Anuradha Dube

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

23

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

9

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

1189-1196

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

Drug resistance in Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Leishmania vaccines: old and new.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunobiology of experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Isolation and partial characterization of surface membranes from Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Evaluation of recombinant gp63, the major Leishmania surface glycoprotein, as a diagnostic molecule for leishmaniasis in vervet monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Identification of two integral membrane proteins of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Cloning of a gene encoding the immunodominant surface antigen of Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunoblotting analysis of the major integral membrane protein antigens of Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Trypanosoma brucei gambiense: partitioning of glycopeptides of bloodstream and procyclic forms in Triton X-114

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Characterization of membrane proteins in detergent solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.06.054

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/15629362

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51820667&oldid=1508500785"